Skip to main content

toppbild-press-1551x278.jpg

Press

Interview with CEO Anna Ljung

Link to video »
  • All pressreleases
  • Regulatory
2024-12-18 | Press release
New terbinafine supplier secured
2024-12-10 | Press release
Moberg Pharma reports topline data in the North American phase 3 study and will regain rights to MOB-015 in EU
2024-11-12 | Press release
Moberg Pharma´s Interim report January - September 2024

Read more »

2024-12-18 | Press release
New terbinafine supplier secured
2024-12-10 | Press release
Moberg Pharma reports topline data in the North American phase 3 study and will regain rights to MOB-015 in EU
2024-11-12 | Press release
Moberg Pharma´s Interim report January - September 2024

Read more press releases »

Latest report

2024-11-12 Moberg Pharma´s Interim report January - September 2024

Contact for press och media:

Anna Ljung, CEO
Phone: +46 8 522 307 08
Email: anna.ljung@mobergpharma.se
 

Subscribe

Get our latest press releases and reports

 

Calendar/presentations

Next calendar event: 2025-02-11 Year-end report 2024

IMAGE BANK  »